NET PROFIT (x1000 EUR)
EMPLOYEES
Arcedi Biotech ApS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-5,664
|
-4,469
|
-1,194 |
| Total assets |
18,403
|
17,000
|
15,454 |
| Current assets |
1,615
|
1,318
|
1,073 |
| Current liabilities |
964
|
850
|
17,698 |
| Equity capital |
-11,512
|
-7,171
|
-3,917 |
| - share capital |
11
|
11
|
11 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-62.6%
|
-42.2%
|
-25.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
167.5%
|
155.1%
|
6.1% |
| Return on equity (ROE) |
49.2%
|
62.3%
|
30.5% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.